
|Videos|September 29, 2016
New Checkpoint Inhibitors Under Investigation in CLL
Author(s)Nitin Jain, MD
Nitin Jain, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, discusses the checkpoint inhibitors under investigation in chronic lymphocytic leukemia (CLL).




















